picolinic acid has been researched along with Central Hypothyroidism in 1 studies
picolinic acid: iron-chelating agent that inhibits DNA synthesis; may interfere with iron-dependent production of stable free organic radical which is essential for ribonucleotide reductase formation of deoxyribonucleotides; RN given refers to parent cpd; structure in Merck Index, 9th ed, #7206
picolinic acid : A pyridinemonocarboxylic acid in which the carboxy group is located at position 2. It is an intermediate in the metabolism of tryptophan.
Excerpt | Relevance | Reference |
---|---|---|
" On each study day, the subjects ingested 1 mg levothyroxine sodium, either taken separately or co-administered with sevelamer hydrochloride (Renagel, a phosphate-binding medication used in the treatment of hyperphosphatemia), chromium picolinate (an over-the-counter nutritional supplement), or ezetimibe (Zetia, a drug used in the treatment of hypercholesterolemia)." | 5.12 | New medications which decrease levothyroxine absorption. ( Carlson, HE; John-Kalarickal, J; Pearlman, G, 2007) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
John-Kalarickal, J | 1 |
Pearlman, G | 1 |
Carlson, HE | 1 |
1 trial available for picolinic acid and Central Hypothyroidism
Article | Year |
---|---|
New medications which decrease levothyroxine absorption.
Topics: Adult; Anticholesteremic Agents; Azetidines; Chelating Agents; Drug Interactions; Ezetimibe; Female; | 2007 |